Category:

Pandemic

Latest

‘By 2030, India might lead the world in almost every category’

“I look out at the year 2030, for example, and I see an India that may lead the world in almost every category…the most populous nation, the most college graduates, the largest middle-class, the most cell phone and Internet users, along with the third largest military and third largest economy, all coexisting in the world’s largest democracy, with 600 million people under the age of 25,” Richard Verma said on Monday.

Covid: India’s ‘R’ number more than 1 in eight states, says govt

Stating that fresh Covid cases are being reported from limited areas, Agrawal said that last week Kerala reported 40.95 per cent of total caseloads in India, followed by Maharashtra (19.43 per cent) and Karnataka (5.94 per cent).

Analysing the district-wise Covid data, Agrawal said that in total, 279 districts reported over 100 cases in the first week of June. However, after one month, such districts’ numbers were confined to 107 and currently only 57 districts are reporting over 100 cases.

A total of 18 districts across the nation have showed the increasing tendency on Covid trajectory from last four weeks, he added.

Centre in SC agrees to waive compound interest on loans up to Rs 2 cr for six-months

In an affidavit filed by Union finance ministry on behalf of the Union of India, it said that the relief to all borrowers in respect of compounding of interest during the period of moratorium would be admissible to the categories specified irrespective of whether the borrowers had availed the moratorium or not.

The government, therefore, has decided that the relief on waiver of compound interest during the six-month moratorium period shall be limited to the most vulnerable category of borrowers. This category of borrowers, in whose case, the compounding of interest will be waived, would be MSME loans and personal loans of up to Rs 2 crore, it said.

read more

COVID-19 vaccine rollout unlikely before fall 2021, experts say

“Experts in our survey offered forecasts on vaccine development that were generally less optimistic than the timeline of early 2021 offered by US public officials,” Jonathan Kimmelman, a professor at McGill University, said in a statement.

“In general they seem to believe that a publicly available vaccine next summer is the best-case scenario with the possibility that it may take until 2022,” said Kimmelman, the senior author on the paper published in the Journal of General Internal Medicine.

read more